Company Filing History:
1 out of 92 
1 out of 15 
1 out of 832,891 Years Active: 1996-2010
Title: Zenro Ikezawa: Innovator in Allergy and Dermatology
Introduction
Zenro Ikezawa is a notable inventor based in Yokohama, Japan, recognized for his impactful contributions in the fields of allergy and dermatology. With two patents to his name, Ikezawa has dedicated his career to developing innovative methods and products that address significant health concerns, particularly atopic dermatitis.
Latest Patents
Ikezawa's latest patents showcase his expertise in medical innovation. One of his key inventions, a method for determining atopic dermatitis using protein markers, aims to identify substances that can serve as disease markers for atopic dermatitis. This method involves measuring the expression of specific proteins and their corresponding genes in skin cells and tissues. The invention addresses the changing expression levels of the proteins in response to inflammation and the predisposition to atopic dermatitis. Alongside this method, he also developed a kit for determining the degree of inflammation and potential risks associated with atopic dermatitis, paving the way for better treatment options.
His second patent focuses on a hypoallergenic wheat preparation, which significantly reduces the content of proteins with molecular weights below 30,000. This innovative product is designed to assist patients with wheat allergies by providing a processed food item that mitigates allergic reactions, enhancing the quality of life for those individuals.
Career Highlights
Zenro Ikezawa has worked with prominent companies, such as Asahi Denka Kogyo Co., Ltd. and Fancl Corporation. His roles at these organizations have allowed him to contribute significantly to research and development, promoting advancements in health-related products.
Collaborations
Throughout his career, Ikezawa has collaborated with esteemed colleagues, including Shumpei Yokota and Kazufumi Tsubaki. These partnerships have enabled him to enhance his research efforts and broaden the impact of his innovations within the medical community.
Conclusion
In conclusion, Zenro Ikezawa stands out as a pivotal figure in innovation related to atopic dermatitis and allergy management. His patents exemplify a commitment to advancing healthcare through scientific exploration and innovation. As research progresses, Ikezawa’s contributions will likely continue to influence treatments, benefitting many individuals affected by allergies and skin conditions.